ATXI — Avenue Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Avenue Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.76	6.71	1.78	2.59	2.85
Net Total Receivables	0.09	0	—	—	—
Prepaid Expenses
Total Current Assets	3.96	6.84	1.85	2.67	2.93
Total Assets	3.96	6.84	1.85	2.67	2.93
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.509	3.58	1.2	0.816	1.1
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.509	2.94	0.268	-0.125	1.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3.45	3.9	1.58	2.8	1.83
Total Liabilities & Shareholders' Equity	3.96	6.84	1.85	2.67	2.93
Total Common Shares Outstanding
Total Preferred Shares Outstanding